Systemic Hypertension in Patients with Aortic Stenosis: Clinical Implications and Principles of Pharmacological...

Area of Science:

• Cardiology
• Internal Medicine

Background:

• Systemic hypertension (HTN) in patients with aortic stenosis (AS) presents a complex clinical challenge.
• Combined HTN and AS impose significant overload on the left ventricle, leading to left ventricular hypertrophy (LVH), increased cardiovascular risks, and mortality.
• Accurate assessment of AS severity can be complicated by the presence of HTN.

Purpose of the Study:

• To review the management strategies for systemic hypertension in patients with concomitant aortic stenosis.
• To highlight the importance of balancing blood pressure reduction with maintaining vital organ perfusion.
• To discuss potential therapeutic options and the need for specific treatment guidelines.

Main Methods:

• Literature review of existing studies and clinical guidelines on managing hypertension in aortic stenosis patients.
• Analysis of the pathophysiological interplay between HTN and AS.
• Evaluation of the impact of HTN control on AS progression and surgical decision-making.

Main Results:

• Effective HTN management is key to preventing AS symptom progression and avoiding premature aortic valve replacement (AVR).
• Angiotensin-converting enzyme inhibitors (ACEi) and angiotensin receptor blockers (ARBs) show potential benefits.
• Echocardiographic reassessment of the aortic valve is recommended after achieving adequate HTN control.

Conclusions:

• Careful management of systemic hypertension is essential in patients with aortic stenosis.
• Improved HTN control can mitigate left ventricular overload and delay the need for AVR.
• Further research is needed to establish specific treatment guidelines for this patient population.